Oral Supplementation of Butyrate Reduces Mucositis and Intestinal Permeability Associated with 5-Fluorouracil Administration

The Jejunum of Diarrhea-Predominant Irritable Bowel Syndrome Shows Molecular Alterations in the Tight Junction Signaling Pathway That Are Associated With Mucosal Pathobiology and Clinical Manifestations

(2012) Cristina Martínez et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Protective effect of Clostridium tyrobutyricum in acute dextran sodium sulphate-induced colitis: differential regulation of tumour necrosis factor-α and interleukin-18 in BALB/c and severe combined immunodeficiency mice

(2011) T. Hudcovic et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

The therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease

(2011) Pamela J Hornby et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis

(2011) Erica L.M. Vieira et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model

(2010) Simone V. Generoso et al.   ARCHIVES OF MICROBIOLOGY

Dietary sodium butyrate supplementation increases digestibility and pancreatic secretion in young milk-fed calves

(2010) P. Guilloteau et al.   JOURNAL OF DAIRY SCIENCE

From the gut to the peripheral tissues: the multiple effects of butyrate

(2010) P. Guilloteau et al.   NUTRITION RESEARCH REVIEWS

Growth factor based therapies and intestinal disease: Is glucagon-like peptide-2 the new way forward?

(2009) Roger Yazbeck et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Butyrate protects Caco-2 cells from Campylobacter jejuni invasion and translocation

(2008) Kim Van Deun et al.   BRITISH JOURNAL OF NUTRITION

Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution

(2008) Pedro M. G. Soares et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Primary eosinophilic disorders of the gastrointestinal tract

(2008) B M Yan et al.   GUT